The perception of nanotechnology and nanomedicine: A worldwide social media study

Nanomedicine

Volumn 9, Issue 10, 2014, Pages 1475-1486

  Sechi, Giovanni ^a,b   Bedognetti, Davide ^c,d   Sgarrella, Francesco ^a   Eperen, Laura Van ^e   Marincola, Francesco M ^c,d   Bianco, Alberto ^f   Delogu, Lucia Gemma ^a  

^a UNIVERSITY OF SASSARI   (Italy)

^b University of Lyon 2 ENS Triangle   (France)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d SIDRA MEDICAL AND RESEARCH CENTER   (Qatar)

^e Van Eperen and Company   (United States)

^f CNRS   (France)

Author keywords

carbon nanotubes; Facebook; graphene; nanomedicine; nanotechnology; public opinions; social network

Indexed keywords

CARBON NANOTUBE; DENDRIMER; GOLD NANOPARTICLE; GRAPHENE; NANOMATERIAL; NANOSHELL; QUANTUM DOT;

ARTICLE; DEMOGRAPHY; ECONOMIC ASPECT; FUNDING; HUMAN; NANOMEDICINE; NANOTECHNOLOGY; PUBLIC OPINION; PUBLICATION; QUESTIONNAIRE; RESEARCH ETHICS; SEX DIFFERENCE; SOCIAL MEDIA; ATTITUDE TO HEALTH; DATA MINING; INTERNATIONAL COOPERATION; STATISTICS AND NUMERICAL DATA;

ATTITUDE TO HEALTH; DATA MINING; INTERNATIONALITY; NANOMEDICINE; NANOTECHNOLOGY; PUBLIC OPINION; SOCIAL MEDIA;

EID: 84907459180     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.14.78     Document Type: Article

References (62)

1. Bosetti R, Vereeck L. Future of nanomedicine: obstables and remedies. Nanomedicine 6(4), 747-755 (2011).
2. Siegrist M, Wiek A, Helland A, Kastenholz H. Risks and nanotechnology: the public is more concerned than experts and industry. Nat. Nanotechnol. 2(2), 67 (2007).
3. Scheufele DA, Corley EA, Dunwoody S, Shih TJ, Hillback E, Guston DH. Scientists worry about some risks more than the public. Nat. Nanotechnol. 2(12), 732-734 (2007).
4. Satterfield T, Kandlikar M, Beaudrie CE, Conti J, Herr Harthorn B. Anticipating the perceived risk of nanotechnologies. Nat. Nanotechnol. 4(11), 752-758 (2009).
5. Priest S, Greenhalgh T, Kramer V. Risk perceptions starting to shift? U.S. citizens are forming opinions about nanotechnology. J. Nanopart. Res. 12(1), 11-20 (2010).
6. Pidgeon N, Harthorn BH, Bryant K, Rogers-Hayden T. Deliberating the risks of nanotechnologies for energy and health applications in the United States and United Kingdom. Nat. Nanotechnol. 4(2), 95-98 (2009).
7. Pidgeon N, Harthorn B, Satterfield T. Nanotechnology risk perceptions and communication: emerging technologies, emerging challenges. Risk Anal. 31(11), 1694-1700 (2011).
8. Kahan DM. Nanotechnology and society: the evolution of risk perceptions. Nat. Nanotechnol. 4(11), 705-706 (2009).
9. Currall SC, King EB, Lane N, Madera J, Turner S. What drives public acceptance of nanotechnology? Nat. Nanotechnol. 1(3), 153-155 (2006).
10. Conti J, Satterfield T, Harthorn BH. Vulnerability and social justice as factors in emergent U.S. nanotechnology risk perceptions. Risk Anal. 31(11), 1734-1748 (2011).
11. Kahan DM, Braman D, Slovic P, Gastil J, Cohen G. Cultural cognition of the risks and benefits of nanotechnology. Nat. Nanotechnol. 4(2), 87-90 (2009).
12. Scheufele DA, Corley EA, Shih TJ, Dalrymple KE, Ho SS. Religious beliefs and public attitudes toward nanotechnology in Europe and the United States. Nat. Nanotechnol. 4(2), 91-94 (2009).
13. Gaskell G, Ten Eyck T, Jackson J, Veltri G. Public attitudes to nanotechnology in Europe and the United States. Nat. Mater. 3(8), 496 (2004).
14. Bottini M, Rosato N, Gloria F, et al. Public optimism towards nanomedicine. Int. J. Nanomed. 6, 3473-3485 (2011).
15. Fujita Y, Yokoyama H, Abe S. Perception of nanotechnology among the general public in Japan. Asian Pacific Nanotechnol. Wkly 4, 1-2 (2006).
16. Einsiedel E. In the public eye: the early landscape of nanotechnology among Canadian and U.S. publics. AZojono 1, 1-10 (2005).
17. Lane J, Bertuzzi S. Research funding. Measuring the results of science investments. Science 331(6018), 678-680 (2011).
18. Bubela T, Nisbet MC, Borchelt R, et al. Science communication reconsidered. Nat. Biotechnol. 27(6), 514-518 (2009).
19. Van Eperen L, Marincola FM. How scientists use social media to communicate their research. J. Transl. Med. 9, 199 (2011).
20. Bedognetti D, Balwit GM, Wang E, et al. SITC/iSBTc Cancer Immunotherapy Biomarkers Resource document: online resources and useful tools -a compass in the land of biomarker discovery. J. Transl. Med. 9, 155 (2011).
21. Thomas DG, Klaessig F, Harper SL, et al. Informatics and standards for nanomedicine technology. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. doi:10.1002/wnan.152 (2011) (Epub ahead of print).
22. Zamboni P. Can Facebook influence funding? Nature 473(7348), 452 (2011).
23. Jain SH. Practicing medicine in the age of Facebook. N. Engl. J. Med. 361(7), 649-651 (2009).
24. Walter E. Think Like Zuck: The Five Business Secrets of Facebooks Improbably Brilliant CEO Mark Zuckerber. Mc-Graw-Hill, NY, USA (2013).
25. Kintisch E. Fish Stymie Scientists, Facebook to the Rescue. http://news.sciencemag.org/technology/2011/04/fishstymie-scientists-facebook-rescue
26. Kosinski M, Stillwell D, Graepel T. Private traits and attributes are predictable from digital records of human behavior. Proc. Natl Acad. Sci. USA 110(15), 5802-5805 (2013).
27. Bond RM, Fariss CJ, Jones JJ, et al. A 61-million-person experiment in social influence and political mobilization. Nature 489(7415), 295-298 (2012).
28. Ugander J, Backstrom L, Marlow C, Kleinberg J. Structural diversity in social contagion. Proc. Natl Acad. Sci. USA 109(16), 5962-5966 (2012).
29. Veltri GA. Microblogging and nanotweets: nanotechnology on Twitter. Public Underst. Sci. 22(7), 832-849 (2013).
30. Thomson Innovation. The leading IP intelligence and collaboration platform . http://thomsonreuters.com/thomson-innovation
31. Bianco A. Graphene: safe or toxic? The two faces of the medal. Angew. Chem. Int. Ed. Engl. 52(19), 4986-4997 (2013).
32. Schipper ML, Nakayama-Ratchford N, David CR, et al. A pilot toxicology study of single-walled carbon nanotubes in a small sample of mice. Nat. Nanotechnol. 3(4), 216-221 (2008).
33. Porter AE, Gass M, Muller K, Skepper JN, Midgley PA, Welland M. Direct imaging of single-walled carbon nanotubes in cells. Nat. Nanotechnol. 2(11), 713-717 (2007).
34. Delogu LG, Vidili G, Venturelli E, et al. Functionalized multiwalled carbon nanotubes as ultrasound contrast agents. Proc. Natl Acad. Sci. USA 109(41), 16612-16617 (2012).
35. Delogu LG, Venturelli E, Manetti R, et al. Ex vivo impact of functionalized carbon nanotubes on human immune cells. Nanomedicine (Lond.) 7(2), 231-243 (2012).
36. Delogu LG, Magrini A, Bergamaschi A, et al. Conjugation of antisense oligonucleotides to PEGylated carbon nanotubes enables efficient knockdown of PTPN22 in T lymphocytes. Bioconjug. Chem. 20(3), 427-431 (2009).
37. De Volder MF, Tawfick SH, Baughman RH, Hart AJ. Carbon nanotubes: present and future commercial applications. Science 339(6119), 535-539 (2013).
38. De la Zerda A, Zavaleta C, Keren S, et al. Carbon nanotubes as photoacoustic molecular imaging agents in living mice. Nat. Nanotechnol. 3(9), 557-562 (2008).
39. Cellot G, Cilia E, Cipollone S, et al. Carbon nanotubes might improve neuronal performance by favouring electrical shortcuts. Nat. Nanotechnol. 4(2), 126-133 (2009).
40. Delogu LG, Stamford SM, Santelli E, et al. Carbon nanotube-based nanocarriers: the importance of keeping it clean. J. Nanosci. Nanotechnol. 10(8), 5293-5301 (2010).
41. Pescatori M, Bedognetti D, Venturelli E, et al. Functionalized carbon nanotubes as immunomodulator systems. Biomaterials 34(18), 4395-4403 (2013).
42. Ponomarenko LA, Gorbachev RV, Yu GL, et al. Cloning of Dirac fermions in graphene superlattices. Nature 497(7451), 594-597 (2013).
43. Bussy C, Ali-Boucetta H, Kostarelos K. Safety considerations for graphene: lessons learnt from carbon nanotubes. Acc. Chem. Res. 46(3), 692-701 (2013).
44. Krishna KV, Ménard-Moyon C, Verma S, Bianco A. Graphene-based nanomaterials for nanobiotechnology and biomedical applications. Nanomedicine (Lond.) 8(10), 1669-1688 (2013).
45. Polls for Facebook. All you need to know about the app in one page. www.facebookpoll.net/faq/
46. Oyewumi MO, Kumar A, Cui Z. Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses. Expert Rev. Vaccines 9(9), 1095-1107 (2010).
47. Sandberg S. Lean In: Women, Work and The Will To Lead. Alfred A Knopf (Ed.). WH Allen, London, UK (2013).
48. DeForge LE, Remick DG. Kinetics of TNF, IL-6, and IL-8 gene expression in LPS-stimulated human whole blood. Biochem. Biophys. Res. Commun. 174(1), 18-24 (1991).
49. Chen H, Roco MC, Li X, Lin Y. Trends in nanotechnology patents. Nat. Nanotechnol. 3(3), 123-125 (2008).
50. Nordmann A, Rip A. Mind the gap revisited. Nat. Nanotechnol. 4(5), 273-274 (2009).
51. Lenk C, Biller-Andorno N. Nanomedicine-emerging or reemerging ethical issues? A discussion of four ethical themes. Med. Health Care Philos. 10(2), 173-184 (2007).
52. Kuiken T. Nanomedicine and ethics: is there anything new or unique?. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 3, 111-118 (2011).
53. Wang LS, Chuang MC, Ho JA. Nanotheranostics-a review of recent publications. Int. J. Nanomed. 7, 4679-4695 (2012).
54. Prabhu P, Patravale V. The upcoming field of theranostic nanomedicine: an overview. J. Biomed. Nanotechnol. 8(6), 859-882 (2012).
55. Toumey C. Rules of engagement. Nat. Nanotechnol. 2(7), 386-387 (2007).
56. Besley JC, Kramer VK, Yao Q, Toumey C. Interpersonal discussion following citizen engagement about nanotechnology: what, if anything, do they say? Sci. Commun. 30, 209 (2008).
57. Burke M. Using facebook after losing a job: differential benefits of strong and weak ties. In: Proceedings of the 2013 Conference on Computer Supported Cooperative Work.. TX, USA, 23-27 February 2013.
58. Toumey C. Does nanotech have a gender? Nat. Nanotechnol. 7(7), 412 (2012).
59. Harthorn B. Encyclopedia of Nanoscience and Society. Guston DH (Ed.). SAGE Publications, CA, USA, 269-271 (2010)
60. Currall SC. Nanotechnology and society. New insights into public perceptions. Nat. Nanotechnol. 4(2), 79-80 (2009).
61. Toumey C. Democratizing nanotech, then and now. Nat. Nanotechnol. 6(10), 605-606 (2011).
62. Toumey C. Hearts and minds and nanotechnology. Nat. Nanotechnol. 4(3), 136-137 (2009).